Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?

@article{Rotondi2018RoleOC,
  title={Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?},
  author={Mario Rotondi and Francesca Coperchini and Francesco Latrofa and Luca Chiovato},
  journal={Frontiers in Endocrinology},
  year={2018},
  volume={9}
}
Tumor-related inflammation does influence the biological behavior of neoplastic cells and ultimately the patient’s outcome. With specific regard to thyroid cancer, the issue of tumor-associated inflammation has been extensively studied and recently reviewed. However, the role of chemokines, which play a crucial role in determining the immuno-phenotype of tumor-related inflammation, was not addressed in previous reviews on the topic. Experimental evidence shows that thyroid cancer cells actively… 

The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition

How different immune cells contribute to thyroid cancer development and the rationale for the antitumor effects of ICIs in combination with BRAF/TK inhibitors are illustrated.

Immune Microenvironment of Thyroid Cancer

A comprehensive review of the immune cells, secreted soluble mediators and immune checkpoints in the immune microenvironment, mechanisms that promoting TC cells immune evasion and existing immunotherapy strategies, and new strategies for TC prognosis prediction and immunotherapy are presented.

Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration

It is found that TC-induced macrophages induced IL-32 expression in TC cells and that TAM-derived TNFα was the main inducer of IL- 32β expression inTC cells, which may be beneficial for TC cell survival through induction of the pro-survival cytokine IL-8.

CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer

A higher CXCL16 expression was associated with macrophage- and angiogenesis-related genes and aggressive phenotypes in PTC and may be a good therapeutic strategy for advanced thyroid cancer.

Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis

The alterations in DNA methylation, histone modifiers, and microRNAs (miRNAs) involved in TCSC survival are described, focusing on the potential of targeting aberrant epigenetic modifications for developing novel therapeutic approaches.

CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer

The tumor microenvironment plays a critical role in development of PTC and CXCL10 may serve as a novel target of precision therapy for this patient population.

Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity

The function of TPL2-driven inflammation to oncogenic functions such as inflammation, proliferation, apoptosis resistance, angiogenesis, metastasis, immunosuppression and immune evasion is reconciled.

Metastatic propagation of thyroid cancer; organ tropism and major modulators.

Different aspects of thyroid cancer metastasis are described by focusing on defective genes and pathways involved in its metastatic spread by utilizing them as diagnostic, prognostic and predictors of the clinical course of patients.

Chemokine Homeostasis in Healthy Volunteers and during Pancreatic and Colorectal Tumor Growth in Murine Models

Blood chemokine level is highly variable and reflects in situ homeostasis and care should be taken when considering chemokines as prognostic parameters or therapeutic targets in cancer.

References

SHOWING 1-10 OF 180 REFERENCES

Role of chemokines in endocrine autoimmune diseases.

Chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.

The Role of Chemokines in Thyroid Carcinoma.

Thyroid cancer cells, like other tumors, possess the ability to corrupt the chemokine system to their advantage by altering cell movement into the tumor microenvironment and affecting all aspects of thyroid cancer progression.

The role of the inflammatory microenvironment in thyroid carcinogenesis.

The inflammatory microenvironment may help to characterize aggressive tumors and to identify patients who would benefit from a more invasive approach, probably sparing the vast majority of patients with an indolent disease from unnecessary procedures.

Role of chemokines in tumor growth.

The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor.

This review focuses on the efforts performed in establishing new pharmacological compounds able to target the chemokine/chemokine receptors system as well as to prevent the secretion of CXCR3-binding chemokines, induced by pro-inflammatory cytokines.

Cancer-Related Inflammation

The role of cancer-associated inflammation and the particular role of MIF in malignant disease is discussed and there is evidence that the cytokine is produced by both malignant cells and infiltrating leukocytes.

Homeostatic chemokine receptors and organ-specific metastasis

A model of 'cellular highways' is proposed to explain the effects of homeostatic chemokines on cancer cells and how they influence metastasis and the conclusion that molecular mechanisms control organ-specific metastasis is supported.

Interleukin-8 and human cancer biology.

  • K. Xie
  • Biology
    Cytokine & growth factor reviews
  • 2001

Chemokines, chemokine receptors, and cancer metastasis

It is interesting that many of chemokine receptors roles are reminiscent of their functions in leukocyte and stem cell trafficking, including adherence of tumor cells to endothelium, extravasation from blood vessels, metastatic colonization, angiogenesis, proliferation and protection from the host response via activation of key survival pathways.

Multiple anti-tumor effects of Reparixin on thyroid cancer

The present study suggests that Reparixin, both alone and in combination with classic chemotherapics, represents a novel potential therapeutic strategy for aggressive forms of TC.
...